Table 1.
Baseline characteristics of patients in the AOK group and the OK group
AOK group (N = 68) | OK group (N = 68) | p value | |
---|---|---|---|
Age, year | 9.90 ± 1.59 | 10.00 ± 1.57 | 0.713* |
Sex, no. (%) | 1.000a | ||
Male | 28 (41.2) | 28 (41.2) | |
Female | 40 (58.8) | 40 (58.8) | |
SER, D | −3.68 ± 1.25 | −3.25 ± 1.26 | 0.052* |
AL, mm | 25.10 ± 0.87 | 25.00 ± 0.85 | 0.472* |
FK, D | 41.95 ± 1.29 | 42.06 ± 1.16 | 0.614* |
SK, D | 43.25 ± 1.56 | 43.14 ± 1.23 | 0.649* |
AVE, D | 42.59 ± 1.37 | 42.60 ± 1.17 | 0.953* |
CCT, μm | 549.53 ± 25.64 | 549.47 ± 29.01 | 0.990* |
NCT, mmHg | 16.06 ± 2.29 | 15.93 ± 2.28 | 0.725* |
Data are presented as mean ± standard deviation, unless otherwise indicated
AOK combination therapy group, OK monotherapy group, SER spherical equivalent refraction, D diopter, AL axial length, mm millimeter, FK flattest keratometry, SK steepest keratometry, AVE average kerotometry, CCT central corneal thickness, μm micrometer, NCT non-contact tonometer, mmHg millimeter of mercury
*Independent group t test
aChi-squared test